BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 28, 2001
View Archived Issues
Enrollment completed for phase I/II StreptAvax trial
Read More
ALT-711 may be effective in improving cardiovascular remodeling in hypertension
Read More
Phase I trial begins for novel site-specific oral therapy for GI disorders
Read More
Antiinflammatory C5a receptor blocker enters clinical testing
Read More
Imidazole antifungal agent NND-502 highlighted at Japanese scientific meeting
Read More
Chimeric gp41 molecule inhibits HIV fusion at nanomolar concentrations
Read More
HEV vaccine advances to phase II trials
Read More
October meeting date set for vote on Microcide/Althexis merger
Read More
NIH funds further development of experimental stroke therapy; PNAS article supports new strategy
Read More
Intratracheal AWD-12-281 significantly reduces LPS-induced BALF neutrophilia in pigs
Read More
BMS-284640 is more potent and more selective for NHE-1 than cariporide
Read More
INS-316 enhances sputum quality for lung cancer diagnosis
Read More
Lead compound targeting fungal N-myristoyltransferase identified by Nippon Roche
Read More
NeoTherapeutics files IND to begin clinical studies with drug targeting severe dementia
Read More
Atrix submits NDA for Leuprogel Three-Month Depot for prostate cancer
Read More
Full enrollment reached in Vasogen psoriasis trial
Read More
Pharmexa cleared to begin phase I/II breast cancer trial in the U.K.
Read More
GenStar's hemophilia A gene therapy trial resumes after previous delay
Read More
ERS highlights: NIK-616 may have advantages for Rx of asthma and COPD
Read More
New PDE4 inhibitor CI-1044 may be useful in COPD, according to ERS presentation
Read More
New dopamine D4 ligands from Lundbeck and potential therapeutic uses
Read More
1-Methylcarbapenems with excellent antibacterial activity, safety and pharmacokinetics
Read More
Potent and selective MCP-1 antagonists identified by Daiichi
Read More
Daiichi's new squalene synthase and cholesterol biosynthesis inhibitors patented
Read More
Eisai presents new sodium channel inhibitors with antiarrhythmic activity
Read More
New series from Teijin inhibits human chymase, particularly mast cell enzyme
Read More
Selective Gardos channel inhibitors useful in sickle cell disease
Read More